IVF HARTMANN HLDGIVF HARTMANN HLDGIVF HARTMANN HLDG

IVF HARTMANN HLDG

No trades
See on Supercharts
Market capitalization
‪327.70 M‬CHF
‪15.15 M‬CHF
‪147.95 M‬CHF
‪638.35 K‬
Beta (1Y)
0.30

About IVF HARTMANN HLDG

CEO
Claus Martini
Headquarters
Neuhausen
Employees (FY)
304
Founded
1871
ISIN
CH0187624256
FIGI
BBG006M6YKV2
IVF HARTMANN Holding AG engages in the business of producing and distributing medical consumer products. It operates through the following segments: Wound Care, Incontinence Management, Infection Management, and Other Group Activities. The Wound Care segment includes modern and traditional wound care products, as well as the first aid product area. The Incontinence Management segment offers products of incontinence, patient hygiene, and medical skin care product range. The Infection Management segment includes disinfectants, surgical drapes, surgical clothing and gloves, disposable surgical instruments, and customer-specific sets. The Other Group Activities segment is involved in various cotton wool, personal care, housekeeping, hygiene products, and product area of self-diagnostics. The company was founded in 1871 and is headquartered in Neuhausen, Switzerland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VBSN is 133.779 CHF — it has increased by 23.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange IVF HARTMANN HLDG stocks are traded under the ticker VBSN.
VBSN stock is 19.13% volatile and has beta coefficient of 0.30. Check out the list of the most volatile stocks — is IVF HARTMANN HLDG there?
Yes, you can track IVF HARTMANN HLDG financials in yearly and quarterly reports right on TradingView.
VBSN stock has risen by 23.65% compared to the previous week, the month change is a 23.65% rise, over the last year IVF HARTMANN HLDG has showed a 17.34% increase.
VBSN net income for the last quarter is ‪8.11 M‬ CHF, while the quarter before that showed ‪7.04 M‬ CHF of net income which accounts for 15.26% change. Track more IVF HARTMANN HLDG financial stats to get the full picture.
Today IVF HARTMANN HLDG has the market capitalization of ‪328.66 M‬, it has decreased by 1.45% over the last week.
IVF HARTMANN HLDG dividend yield was 2.86% in 2023, and payout ratio reached 50.31%. The year before the numbers were 2.09% and 52.87% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, VBSN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IVF HARTMANN HLDG stock right from TradingView charts — choose your broker and connect to your account.
VBSN reached its all-time high on Apr 19, 2023 with the price of 117.106 CHF, and its all-time low was 104.161 CHF and was reached on Oct 24, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 304.00 employees. See our rating of the largest employees — is IVF HARTMANN HLDG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IVF HARTMANN HLDG EBITDA is ‪22.34 M‬ CHF, and current EBITDA margin is 11.89%. See more stats in IVF HARTMANN HLDG financial statements.